FIELD: pharmacy. SUBSTANCE: invention relates to new chemical compositions, namely, compositions containing natural amino acids and trace elements that can be used in medicine. Composition has the following components, g/l: valine, 0.3-3.3; leucine, 0.4-4.4; isoleucine, 0.3-2.90; phenylalanine, 0.4-4.00; tryptophan, 0.1-1.00; lysine hydrochloride, 0.4-4.10; methionine, 3.0-4.40; histidine, 2.0-14.2; serine, 5.0-28.6; glutamate sodium, 6.0-32.9; and also, mole/l: manganese (II) dichloride, (0.3-1.6) x 10-3; cobalt (II) dichloride, (0.3-1.5) x 10-5; copper (II) dichloride, (0.9-3.7) x 10-4; and distilled water. This composition shows antiblastic activity without hematotoxic effect, antihypoxic effect and low toxicity. EFFECT: enhanced effectiveness of composition, improved properties. 1 cl, 5 ex, 4 tbl
Title | Year | Author | Number |
---|---|---|---|
COMPOSITION OF AMINO ACIDS WITH TRACE ELEMENTS AND CALCIUM SHOWING ANTITUMOR, ANTIDEPRESSANT AND ANTI-ARRHYTHMIC ACTIVITY | 1999 |
|
RU2151596C1 |
COMPOSITION OF AMINO ACIDS WITH TRACE ELEMENTS ELICITING ANTIARRHYTHMIC ACTIVITY | 1999 |
|
RU2173553C2 |
L-α-AMINO -γ-LITHIUM METHYLMERCAPTOBUTYRATE HAVING ANTITUMOR AND ANTIULCER ACTIVITY | 1994 |
|
RU2114853C1 |
TETRAKIS-(L-HISTIDINATO)-μ-PEROXYDICOBALT)III HEPTAHYDRATE HAVING ANTIANEMIC, RADIOPROTECTIVE AND ANTIARRHYTHMIC ACTIVITIES | 1999 |
|
RU2151773C1 |
PREPARATION FOR TREATMENT OF PATIENT WITH CANCER SKIN AND PRECANCER SKIN DISEASES | 1998 |
|
RU2146927C1 |
NOVEL CHELATE COMPOUND OF OXOVANADIUM (IV) WITH ISONICOTINIC ACID HYDRAZIDE SHOWING ANTIDIABETIC ACTION AND ELICITING ANTIMYCOBACTERIAL ACTIVITY | 1999 |
|
RU2190618C2 |
DERIVATIVES OF 2-OXO-3,3,5-TRIMETHYL-1,2-OXAPHOSPHOLENE-4 SHOWING ANTIBLASTOMA ACTIVITY | 1990 |
|
SU1769528A1 |
PHOSPHINIC ACID ESTERS OR THEIR PHYSIOLOGICALLY ACCEPTABLE SALTS, PHARMACEUTICAL COMPOSITION BASED ON ABOVE COMPOUNDS, AND METHOD FOR CORRECTION OF DISTURBANCES IN METABOLIC PROCESSES IN BRAIN | 1994 |
|
RU2141961C1 |
METHOD OF PURULENT WOUNDS TREATMENT | 1997 |
|
RU2131255C1 |
BISIMIDAZOLE-(1,10)-PHENENTHROLINE PLATINUM (III) DICHLORIDE SHOWING CYTOSTATIC ANTITUMOR ACTIVITY | 1995 |
|
RU2089555C1 |
Authors
Dates
1999-02-10—Published
1994-07-04—Filed